Did the Decline in PSA Testing Lead to More Cases of Advanced Prostate Cancer?
FRIDAY, Oct. 28, 2022 (HealthDay News) — A large new study of U.S. veterans suggests that when prostate cancer screening rates go down, the number of men diagnosed with advanced cancer then rises.Researchers found that across 128 U.S. veterans health…
Learn MoreU.S. Cancer Death Rates Continue to Decline
THURSDAY, Oct. 27, 2022 (HealthDay News) — The latest statistics from the U.S. National Cancer Institute (NCI) show a continuing decline in the number of Americans who die from cancer, although there’s been little change in the number of new cancer c…
Learn MoreRobotic Prostate Cancer Surgery Tied to Financial Harm in Younger Patients
TUESDAY, Oct. 18, 2022 (HealthDay News) — Younger patients have a higher risk for financial toxicity following robotic prostate cancer surgery, according to a study published in the November issue of The Journal of Urology.Oktay Özman, M.D., from the…
Learn MoreCoffee Intake Linked to Longer Prostate Cancer-Specific Survival
THURSDAY, Sept. 22, 2022 (HealthDay News) — High coffee intake is associated with longer prostate cancer-specific survival (PCSS) for certain subgroups of men, including those with the CYP1A2 AA genotype, according to a study published online Aug. 19…
Learn MoreNeoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer
THURSDAY, Sept. 22, 2022 (HealthDay News) — Neoadjuvant therapy with a novel hormonal agent prior to radical prostatectomy is associated with better outcomes for men with high-risk prostate cancer versus upfront radical prostatectomy, according to a …
Learn MoreCoffee Might Give Some Men an Edge Battling Prostate Cancer
MONDAY, Sept. 19, 2022 (HealthDay News) — For some men battling prostate cancer, drinking coffee may offer not just a quick pick-me-up but longer survival.Research is still in the early phases, but a new study finds an association between a genotype …
Learn MorePSA Screening Tied to Lower Risk for Prostate Cancer Mortality
WEDNESDAY, Aug. 10, 2022 (HealthDay News) — Prostate-specific antigen (PSA) screening is associated with a decreased risk for prostate cancer-specific mortality (PCSM) among both Black and White men, according to a study published online Aug. 4 in JA…
Learn MoreADT Use for Prostate Cancer Linked to Increased Risk for CVD Death
FRIDAY, July 29, 2022 (HealthDay News) — For patients with prostate cancer, use of androgen-deprivation therapy (ADT) is associated with an increased risk for cardiovascular disease (CVD) death, according to a study published online July 26 in The Ag…
Learn MoreUn tratamiento para el cáncer de próstata podría aumentar los riesgos cardiacos
MIÉRCOLES, 27 de julio de 2022 (HealthDay News) — La terapia hormonal es una opción de tratamiento común para el cáncer de próstata, pero podría aumentar el riesgo de muerte por enfermedad cardiaca, sobre todo en los hombres mayores, encuentra un est…
Learn MoreProstate Cancer Treatment May Raise Heart Risks
WEDNESDAY, July 27, 2022 (HealthDay News) — Hormone therapy is a common treatment option for prostate cancer, but it may increase the risk of death from heart disease, especially in older men, a new study finds.Dr. William Dahut, a prostate cancer re…
Learn More